Skip to main content
GEHC
NASDAQ Industrial Applications And Services

GE HealthCare Exceeds Q4 & FY25 Expectations, Issues Strong 2026 Guidance

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$80.79
Mkt Cap
$35.886B
52W Low
$57.65
52W High
$94.8
Market data snapshot near publication time

summarizeSummary

GE HealthCare reported Q4 and full-year 2025 results exceeding expectations and provided strong 2026 guidance, projecting continued growth and margin expansion.


check_boxKey Events

  • Exceeded Q4 & FY25 Expectations

    The company reported Q4 2025 revenue of $5.7 billion (up 7.1%, 4.8% organic) and Adjusted EPS of $1.44, exceeding market expectations. Full-year 2025 revenue reached $20.6 billion (up 4.8%, 3.5% organic) with Adjusted EPS of $4.59, also surpassing forecasts.

  • Strong 2026 Guidance Issued

    GE HealthCare introduced 2026 full-year guidance, projecting organic revenue growth of 3.0% to 4.0%, Adjusted EBIT margin expansion of 50 to 80 basis points (15.8% to 16.1%), and Adjusted EPS in the range of $4.95 to $5.15, representing 7.9% to 12.3% growth year-over-year.

  • Strategic Capital Deployment

    The company executed $200 million in share repurchases during 2025 under a $1.0 billion authorized program. Additionally, it announced the planned $2.3 billion acquisition of Intelerad, expected to close in the first half of 2026, to advance cloud-enabled enterprise imaging.

  • Operational Resilience and Cash Flow

    Despite negative impacts from tariff expense and unfavorable mix on margins, the company demonstrated operational resilience. It generated $916 million in Free Cash Flow for Q4 2025 and $1.5 billion for the full year, supporting growth ambitions and capital returns.


auto_awesomeAnalysis

GE HealthCare Technologies Inc. reported strong fourth quarter and full-year 2025 financial results, surpassing both top-line and earnings per share expectations. The company demonstrated operational resilience despite tariff impacts, achieving robust organic revenue growth across key segments. The introduction of optimistic 2026 guidance, projecting continued organic revenue growth, Adjusted EBIT margin expansion, and significant Adjusted EPS growth, signals confidence in future performance. Strategic capital deployment, including a share repurchase program and a planned $2.3 billion acquisition, further underscores the company's commitment to enhancing shareholder value and expanding its cloud-enabled enterprise imaging capabilities.

At the time of this filing, GEHC was trading at $80.79 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $35.9B. The 52-week trading range was $57.65 to $94.80. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed GEHC - Latest Insights

GEHC
Apr 29, 2026, 8:06 AM EDT
Source: Reuters
Importance Score:
9
GEHC
Apr 29, 2026, 6:26 AM EDT
Filing Type: 10-Q
Importance Score:
8
GEHC
Apr 29, 2026, 6:25 AM EDT
Filing Type: 8-K
Importance Score:
7
GEHC
Apr 29, 2026, 6:20 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
GEHC
Apr 21, 2026, 10:17 AM EDT
Source: Reuters
Importance Score:
7
GEHC
Apr 16, 2026, 4:55 PM EDT
Source: Reuters
Importance Score:
7
GEHC
Mar 17, 2026, 9:14 AM EDT
Filing Type: 8-K
Importance Score:
7
GEHC
Feb 04, 2026, 6:28 AM EST
Filing Type: 10-K
Importance Score:
8
GEHC
Feb 04, 2026, 6:25 AM EST
Filing Type: 8-K
Importance Score:
8